ArticleInternational cancer conference journal2023
Intrahepatic cholangiocarcinoma with FGFR2 fusion gene positive that responded to pemigatinib and caused hypophosphatemia.
Yoshinori Kikuchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.